Affinity-purified soluble FcϵRII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism
- 28 February 1991
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 27 (2), 113-118
- https://doi.org/10.1016/0165-2478(91)90137-y
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- The B-cell binding site on human immunoglobulin ENature, 1989
- Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigenEuropean Journal of Immunology, 1988
- Histamine-releasing factors and IgE heterogeneityJournal of Allergy and Clinical Immunology, 1988
- Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)European Journal of Immunology, 1988
- The mast cell binding site on human immunoglobulin ENature, 1988
- Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE‐binding factor analogous to that spontaneously released by lymphoblastoid B cell linesEuropean Journal of Immunology, 1988
- Use of synthetic peptides in the production and characterization of antibodies directed against predetermined specificities in rat immunoglobulin EMolecular Immunology, 1986
- Changes in cellular levels of cyclic AMP in rat mast cells during secretion of histamine induced by immunoglobulin E decapeptide and ACTH(1–24) peptideBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1983
- An automated fluorimetric assay for the rapid determination of histamine in biological fluidsLife Sciences, 1973